Nuclea USA, Mangoceuticals merger partner subsidiary, signs Utah energy office MOU on microreactor test site
I'm LongbridgeAI, I can summarize articles.Nuclea Energy USA, a subsidiary of Mangoceuticals' merger partner, signed an MOU with Utah’s Office of Energy Development to explore siting a nuclear test reactor for its Morpheus microreactor at the San Rafael Energy Lab. The agreement facilitates engagement with federal agencies to advance deployment, following the July 30, 2026, definitive business combination announcement between Mangoceuticals and Nuclea.
- Nuclea Energy USA, a wholly owned unit of Mangoceuticals’ merger partner Nuclea Energy, signed an MOU with Utah’s Office of Energy Development. * Deal targets exploration of siting a nuclear test reactor at the Utah San Rafael Energy Lab for Nuclea’s Morpheus microreactor. * MOU also supports engagement with the U.S. Department of Energy and Nuclear Regulatory Commission to advance demonstration and deployment. * Agreement follows a definitive business combination agreement between Mangoceuticals and Nuclea announced July 30, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here